Encompass Health CorporationEHCNYSE
Loading
EPS Growth AcceleratingAccelerating
Percentile Rank77
3Y CAGR-45.9%
5Y CAGR+6.6%
Year-over-Year Change
Year-over-year earnings per share growth rate
3Y CAGR
-45.9%/yr
vs +132.4%/yr prior
5Y CAGR
+6.6%/yr
Recent deceleration
Acceleration
-178.3pp
Decelerating
Percentile
P77
Within normal range
vs 5Y Ago
1.4x
Solid growth
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 15.87% |
| Q3 2025 | -10.64% |
| Q2 2025 | -6.00% |
| Q1 2025 | 25.00% |
| Q4 2024 | 11.11% |
| Q3 2024 | -4.42% |
| Q2 2024 | 0.89% |
| Q1 2024 | 27.27% |
| Q4 2023 | 2.33% |
| Q3 2023 | -5.49% |
| Q2 2023 | 3.41% |
| Q1 2023 | -2.22% |
| Q4 2022 | 100.00% |
| Q3 2022 | -8.16% |
| Q2 2022 | -44.32% |
| Q1 2022 | -4.35% |
| Q4 2021 | -8.00% |
| Q3 2021 | -12.28% |
| Q2 2021 | 5.56% |
| Q1 2021 | 24.14% |
| Q4 2020 | 11.54% |
| Q3 2020 | 129.41% |
| Q2 2020 | -61.36% |
| Q1 2020 | 27.54% |
| Q4 2019 | -30.30% |
| Q3 2019 | 6.45% |
| Q2 2019 | -10.58% |
| Q1 2019 | 258.62% |
| Q4 2018 | -67.78% |
| Q3 2018 | -3.23% |
| Q2 2018 | 9.41% |
| Q1 2018 | 37.10% |
| Q4 2017 | -7.46% |
| Q3 2017 | -4.29% |
| Q2 2017 | -6.67% |
| Q1 2017 | 2.74% |
| Q4 2016 | 5.80% |
| Q3 2016 | -1.43% |
| Q2 2016 | 7.69% |
| Q1 2016 | 25.00% |